not available
KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation / Serrano, César; Wang, Yuexiang; Mariño Enríquez, Adrián; Lee, Jen Chieh; Ravegnini, Gloria; Morgan, Jeffrey A.; Bertagnolli, Monica M.; Beadling, Carol; Demetri, George D.; Corless, Christopher L.; Heinrich, Michael C.; Fletcher, Jonathan A.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - ELETTRONICO. - 33:22(2015), pp. e93-e96. [10.1200/JCO.2013.48.7488]
KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation
RAVEGNINI, GLORIA;
2015
Abstract
not availableFile in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
